Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,015 | -42,366 | -21,726 | -104,199 | -83,354 |
| Depreciation Amortization | 167 | 112 | 56 | 199 | 150 |
| Accounts payable and accrued liabilities | 234 | 438 | 806 | -1,786 | -930 |
| Other Working Capital | 1,981 | 152 | -299 | -3,447 | -3,631 |
| Other Operating Activity | 6,663 | 4,849 | 1,833 | 13,125 | 7,826 |
| Operating Cash Flow | $-52,970 | $-36,815 | $-19,330 | $-96,108 | $-79,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,186 | -14,616 | -51,984 | 63,814 | 85,584 |
| PPE Investments | -56 | -34 | -12 | -357 | -298 |
| Investing Cash Flow | $-24,242 | $-14,650 | $-51,996 | $63,457 | $85,286 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 508 | 431 | 298 | 1,327 | 920 |
| Financing Cash Flow | $508 | $431 | $298 | $1,327 | $920 |
| Beginning Cash Position | 101,099 | 101,099 | 101,099 | 132,423 | 132,423 |
| End Cash Position | 24,395 | 50,065 | 30,071 | 101,099 | 138,690 |
| Net Cash Flow | $-76,704 | $-51,034 | $-71,028 | $-31,324 | $6,267 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,970 | -36,815 | -19,330 | -96,108 | -79,939 |
| Capital Expenditure | -56 | -34 | -12 | -370 | -305 |
| Free Cash Flow | -53,026 | -36,849 | -19,342 | -96,478 | -80,244 |